Literature DB >> 10419564

Kainate receptors coupled to G(i)/G(o) proteins in the rat hippocampus.

R A Cunha1, J O Malva, J A Ribeiro.   

Abstract

Kainate receptors are a subtype of ionotropic glutamate receptors, permeable to cations and thus expected to have an excitatory depolarizing action on neurons. However, kainate receptor activation inhibits gamma-aminobutyric acid release in the hippocampus through activation of protein kinase C in a pertussis toxin-dependent manner, suggesting a coupling of kainate receptors to G proteins. Thus, we directly investigated the G protein coupling of kainate receptors in the rat hippocampus by using a selective kainate receptor agonist, [(3)H](2S,4R)-4-methylglutamate ([(3)H]MGA). [(3)H]MGA bound to a single site to hippocampal membranes with a K(D) value of 32 nM and a B(max) value of 1024 fmol/mg protein. This binding likely represents kainate receptors because it was displaced by domoate (K(i) = 4 nM), kainate (K(i) = 11 nM), and 6-cyano-7-nitroquinoxaline-2,3-dione (K(i) = 1.4 microM), but not by alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (K(i) > 10 microM), (RS)-alpha-methyl-4-phosphonophenylglycine (K(i) > 10 microM), or (+/-)-1-aminocyclopentane-trans-1,3-dicarboxylic acid (K(i) > 10 microM). Guanylylimidodiphosphate (30 microM), which uncouples all G protein-coupled receptors, shifted to the right the saturation curve of [(3)H]MGA (K(D) = 133 nM). This effect was mimicked by pretreatment of hippocampal membranes with modifiers of G(i)/G(o) proteins [30 microM N-ethylmaleimide (K(D) = 98 nM) or 25 microgram/ml pertussis toxin (K(D) = 95 nM)] but not by a modifier of G(s) proteins [50 microgram/ml cholera toxin (K(D) = 32 nM)]. Treatment of solubilized hippocampal membranes with pertussis toxin (25 microgram/ml) decreased [(3)H]MGA affinity (K(D) = 105-113 nM), which was recovered by reconstitution of these pretreated solubilized hippocampal membranes with G(i)/G(o) proteins (K(D) = 41-76 nM). These results indicate that hippocampal kainate receptors are coupled to G(i)/G(o) proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419564     DOI: 10.1124/mol.56.2.429

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

3.  Kainate receptors depress excitatory synaptic transmission at CA3-->CA1 synapses in the hippocampus via a direct presynaptic action.

Authors:  M Frerking; D Schmitz; Q Zhou; J Johansen; R A Nicoll
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

Review 4.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

5.  Regulation of vesicular acetylcholine transporter by the activation of excitatory amino acid receptors in the avian retina.

Authors:  Nelson Enrique Loureiro-dos-Santos; Marco Antonio M Prado; Ricardo Augusto de Melo Reis; Patrícia F Gardino; Maria Christina F de Mello; Fernando G de Mello
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

6.  Calcium-independent inhibitory G-protein signaling induces persistent presynaptic muting of hippocampal synapses.

Authors:  Devon C Crawford; Chun Yun Chang; Krzysztof L Hyrc; Steven Mennerick
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

Review 7.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

8.  Pharmacological Preconditioning with GYKI 52466: A Prophylactic Approach to Neuroprotection.

Authors:  Chelsea S Goulton; Anna R Patten; John R Kerr; D Steven Kerr
Journal:  Front Neurosci       Date:  2010-08-03       Impact factor: 4.677

Review 9.  Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.

Authors:  László Köles; Erzsébet Kató; Adrienn Hanuska; Zoltán S Zádori; Mahmoud Al-Khrasani; Tibor Zelles; Patrizia Rubini; Peter Illes
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

10.  Regulation of chemoconvulsant-induced seizures by store-operated Orai1 channels.

Authors:  Kotaro Hori; Shogo Tsujikawa; Michaela M Novakovic; Megumi Yamashita; Murali Prakriya
Journal:  J Physiol       Date:  2020-09-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.